Invention Grant
- Patent Title: Treatment of Aspergillus infections with alpha thymosin peptides
- Patent Title (中): 用α胸腺肽处理曲霉菌感染
-
Application No.: US10551341Application Date: 2004-03-29
-
Publication No.: US08207294B2Publication Date: 2012-06-26
- Inventor: Guido Rasi , Enrico Garaci , Francesco Bistoni , Luigina Romani , Paolo Di Francesco
- Applicant: Guido Rasi , Enrico Garaci , Francesco Bistoni , Luigina Romani , Paolo Di Francesco
- Applicant Address: US CA Foster City
- Assignee: SciClone Pharmaceuticals, Inc.
- Current Assignee: SciClone Pharmaceuticals, Inc.
- Current Assignee Address: US CA Foster City
- Agency: Cooley LLP
- International Application: PCT/US2004/009550 WO 20040329
- International Announcement: WO2004/087067 WO 20041014
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/22
Abstract:
A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The method is particularly useful in preventing an infection by Aspergillus in an immuno-compromised host being treated with a bone marrow transplantation.
Public/Granted literature
- US20070129292A1 Treatment of aspergillus infections with alpha thymosin peptides Public/Granted day:2007-06-07
Information query
IPC分类:
